Industry’s ‘Regulatory Commitments’ Concept Draws FDA’s Interest

An industry team is talking up the potential role of what it’s calling ‘regulatory commitments’ to prospectively manage post-approval changes in a way that’s more consistent worldwide. FDA has responded with interest and is engaged in discussions on the idea.